High activation of SARS 3Cl protease inhibitors and development of anti-COVID-19 drugs
- Funded by KAKENHI
- Total publications:0 publications
Grant number: 21K05417
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$32,760Funder
KAKENHIPrincipal Investigator
Yasunao Hattori UnspecifiedResearch Location
JapanLead Research Institution
Kyoto Pharmaceutical UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable